Skip to main content
SpringerLink
Log in

Radiological Detection and Assessment of Tumor Response

  • Chapter
Liver Radioembolization with 90Y Microspheres

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

  • 1030 Accesses

Abstract

The liver is the most common site of metastatic spread in malignancies. In autopsy studies the incidence of hepatic métastases is up to 100%, depending on the primary tumor. Even if this fact represents the final status of a malignancy, about half of all patients dying from a malignant disease will have apparent hepatic métastases. The risk of developing hepatic metastases varies widely among different types of primary malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, Dahmen G, Bockisch A, Debatin JF, Ruehm SG (2003) Whole-body dual-modality PET-CT and whole-body MRI for tumor staging in oncology. Jama 290:3199–3206

    Article  PubMed  CAS  Google Scholar 

  2. Arulampalam TH, Francis DL, Visvikis D, Taylor I, Ell PJ (2004) FDG-PET for the pre-operative evaluation of colorectal liver metastases. Eur J Surg Oncol 30:286–291

    Article  PubMed  CAS  Google Scholar 

  3. Barker DW, Zagoria RJ, Morton KA, Kavanagh PV, Shen P (2005) Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET-CT. AJR Am J Roentgenol 184:1096–1102

    PubMed  Google Scholar 

  4. Barkhausen J, Quick HH, Lauenstein T, Goyen M, Ruehm SG, Laub G, Debatin JF, Ladd ME (2001) Whole-body MR imaging in 30 seconds with real-time true FISP and a continuously rolling table platform: feasibility study. Radiology 220:252–256

    PubMed  CAS  Google Scholar 

  5. Belton AL, Saini S, Liebermann K, Boland GW, Halpern EF (2003) Tumour size measurement in an oncology clinical trial: comparison between off-site and on-site measurements. Clin Radiol 58:311–314

    Article  PubMed  CAS  Google Scholar 

  6. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, Jerin J, Young J, Byars L, Nutt R (2000) A com-bined PET-CT scanner for clinical oncology. J Nucl Med 41:1369–1379

    PubMed  CAS  Google Scholar 

  7. Böhm B, Voth M, Geoghegan J, Hellfritzsch H, Petrovich A, Scheele J, Gottschild D (2004) Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J Cancer Res Clin Oncol 130:266–272

    Article  PubMed  Google Scholar 

  8. Cohade C, Osman M, Leal J, Wahl RL (2003) Direct comparison of (18)F-FDG PET and PET-CT in patients with colorectal carcinoma. J Nucl Med 44:1797–1803

    PubMed  Google Scholar 

  9. Delbeke D, Vitola JV, Sandier MP, Arildsen RC, Powers TA, Wright JK Jr, Chapman WC, Pinson CW (1997) Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38:1196–1201

    PubMed  CAS  Google Scholar 

  10. Delbeke D, Martin WH (2004) PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med 34:209–223

    Article  PubMed  Google Scholar 

  11. Deng J, Miller FH, Rhee TK, Sato KT, Mulcahy MF, Kulik LM, Salem R, Omary RA, Larson AC (2006) Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. J Vasc Interv Radiol 17:1195–1200

    Article  PubMed  Google Scholar 

  12. Eustace S, Tello R, DeCarvalho V, Carey J, Wroblicka JT, Melhem ER, Yucel EK (1997) A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169:1655–1661

    PubMed  CAS  Google Scholar 

  13. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM (2004) Five-year survival after resection of hepatic métastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240:438–447; discussion 447-450

    Article  PubMed  Google Scholar 

  14. Griswold MA, Jakob PM, Heidemann RM, Nittka M, Jellus V, Wang J, Kiefer B, Haase A (2002) Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 47:1202–1210

    Article  PubMed  Google Scholar 

  15. James K, Eisenhauer E, Christian M, Terenziani M, Vena D, Muldal A, Therasse P (1999) Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst 91:523–528

    Article  PubMed  CAS  Google Scholar 

  16. Kamel IR, Bluemke DA (2002) Magnetic resonance imaging of the liver: assessing response to treatment. Top Magn Reson Imaging 13:191–200

    Article  PubMed  Google Scholar 

  17. Kapoor V, McCook BM, Torok FS (2004) An introduction to PET-CT imaging. Radiographics 24:523–543

    Article  PubMed  Google Scholar 

  18. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF (2002) Detection of hepatic métastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224:748–756

    Article  PubMed  Google Scholar 

  19. Kramer H, Schoenberg SO, Nikolaou K, Huber A, Struwe A, Winnik E, Wintersperger BJ, Dietrich O, Kiefer B, Reiser MF (2005) Cardiovascular screening with parallel imaging techniques and a whole-body MR imager. Radiology 236:300–310

    Article  PubMed  Google Scholar 

  20. Langenhoff BS, Oyen WJ, Jager GJ, Strijk SP, Wobbes T, Corstens FH, Ruers TJ (2002) Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol 20:4453–4458

    Article  PubMed  CAS  Google Scholar 

  21. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507

    Article  PubMed  Google Scholar 

  22. Lauenstein TC, Goehde SC, Herborn CU, Treder W, Ruehm SG, Debatin JF, Barkhausen J (2002) Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study. AJR Am J Roentgenol 179:445–449

    PubMed  Google Scholar 

  23. Lauenstein TC, Goehde SC, Herborn CU, Goyen M, Oberhoff C, Debatin JF, Ruehm SG, Barkhausen J (2004) Whole-body MR imaging: evaluation of patients for métastases. Radiology 233:139–148

    Article  PubMed  Google Scholar 

  24. Lee VS, Lavelle MT, Rofsky NM, Laub G, Thomasson DM, Krinsky GA, Weinreb JC (2000) Hepatic MR imaging with a dynamic contrast-enhanced isotropic volumetric interpolated breath-hold examination: feasibility, reproducibility, and technical quality. Radiology 215:365–372

    PubMed  CAS  Google Scholar 

  25. Low RN, Semelka RC, Worawattanakul S, Alzate GD (2000) Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT in 164 patients. J Magn Reson Imaging 12:269–277

    Article  PubMed  CAS  Google Scholar 

  26. Mazumdar M, Smith A, Schwartz LH (2004) A statistical simulation study finds discordance between WHO criteria and RECIST guideline. J Clin Epidemiol 57:358–365

    Article  PubMed  Google Scholar 

  27. Meta J, Seltzer M, Schiepers C, Silverman DH, Ariannejad M, Gambhir SS, Phelps ME, Valk P, Czernin J (2001) Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician’s perspective. J Nucl Med 42:586–590

    PubMed  CAS  Google Scholar 

  28. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207–214

    Article  PubMed  CAS  Google Scholar 

  29. Nelson RC, Chezmar JL, Sugarbaker PH, Bernardino ME (1989) Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. Radiology 172:27–34

    PubMed  CAS  Google Scholar 

  30. Ogunbiyi OA, Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Birnbaum EH, Fleshman JW, Read TE, Philpott GW, Kodner IJ (1997) Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4:613–620

    Article  PubMed  CAS  Google Scholar 

  31. Park JO, Lee SI, Song SY, Kim K, Kim WS, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Lee KS, Park K (2003) Measuring response in solid tumors: comparison of RECIST and WHO response criteria. Jpn J Clin Oncol 33:533–537

    Article  PubMed  Google Scholar 

  32. Pelosi E, Messa C, Sironi S, Picchio M, Landoni C, Bettinardi V, Gianolli L, Del Maschio A, Gilardi MC, Fazio F (2004) Value of integrated PET-CT for lesion localisation in cancer patients: a comparative study. Eur J Nucl Med Mol Imaging 31:932–939

    Article  PubMed  Google Scholar 

  33. Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentier TK, Garbe C, Brechtel K, Vonthein R, Bares R, Claussen CD, Schlemmer HP (2007) Prospective comparison of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 43:557–564

    Article  PubMed  Google Scholar 

  34. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P (1999) SENSE: sensitivity encoding for fast MRI. Magn Reson Med 42:952–962

    Article  PubMed  CAS  Google Scholar 

  35. Rofsky NM, Lee VS, Laub G, Pollack MA, Krinsky GA, Thomasson D, Ambrosino MM, Weinreb JC (1999) Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 212:876–884

    PubMed  CAS  Google Scholar 

  36. Rohren EM, Paulson EK, Hagge R, Wong TZ, Killius J, Clavien PA, Nelson RC (2002) The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic métastases from colorectal cancer. Clin Nucl Med 27:550–555

    Article  PubMed  Google Scholar 

  37. Ruers TJ, Langenhoff BS, Neeleman N, Jager GJ, Strijk S, Wobbes T, Corstens FH, Oyen WJ (2002) Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 20:388–395

    Article  PubMed  CAS  Google Scholar 

  38. Sahani DV, Kalva SP, Fischman AJ, Kadavigere R, Blake M, Hahn PF, Saini S (2005) Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR Am J Roentgenol 185:239–246

    PubMed  Google Scholar 

  39. Schlemmer HP, Schafer J, Pfannenberg C, Radny P, Kor-chidi S, Muller-Horvat C, Nagele T, Tomaschko K, Fenchel M, Claussen CD (2005) Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: initial experiences. Invest Radiol 40:64–71

    Article  PubMed  Google Scholar 

  40. Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Schmidt M, Reiser MF, Schoenberg SO (2005) High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol 40:743–753

    Article  PubMed  Google Scholar 

  41. Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA (2004) Does the novel PET-CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240:1027–1034; discussion 1035-1036

    Article  PubMed  Google Scholar 

  42. Semelka RC, Martin DR, Balci C, Lance T (2001) Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13:397–401

    Article  PubMed  CAS  Google Scholar 

  43. Soyer P, Levesque M, Elias D, Zeitoun G, Roche A (1992) Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography. Radiology 183:541–544

    PubMed  CAS  Google Scholar 

  44. Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF (1999) Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 23:123–129

    Article  PubMed  CAS  Google Scholar 

  45. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M (2004) Diffusion weighted whole body imaging with background body signal suppression (DWIBS):technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22:275–282

    PubMed  Google Scholar 

  46. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216

    Article  PubMed  CAS  Google Scholar 

  47. Topal B, Flamen P, Aerts R, D’Hoore A, Filez L, Van Cutsem E, Mortelmans L, Penninckx F (2001) Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases. Eur J Surg Oncol 27:175–179

    Article  PubMed  CAS  Google Scholar 

  48. Torizuka T, Tamaki N, Inokuma T, Magata Y, Yonekura Y, Tanaka A, Yamaoka Y, Yamamoto K, Konishi J (1994) Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med 35:1965–1969

    PubMed  CAS  Google Scholar 

  49. Tran LN, Brown MS, Goldin JG, Yan X, Pais RC, McNitt-Gray MF, Gjertson D, Rogers SR, Aberle DR (2004) Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography. Acad Radiol 11:1355–1360

    Article  PubMed  Google Scholar 

  50. Truant S, Huglo D, Hebbar M, Ernst O, Steinling M, Pruvot FR (2005) Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 92:362–369

    Article  PubMed  CAS  Google Scholar 

  51. Tutt AN, Plunkett TA, Barrington SF, Leslie MD (2004) The role of positron emission tomography in the management of colorectal cancer. Colorectal Dis 6:2–9

    Article  PubMed  CAS  Google Scholar 

  52. Valk PE, Abella-Columna E, Haseman MK, Pounds TR, Tesar RD, Myers RW, Greiss HB, Hofer GA (1999) Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 134:503–511; discussion 511-513

    Article  PubMed  CAS  Google Scholar 

  53. Vitola JV, Delbeke D, Meranze SG, Mazer MJ, Pinson CW (1996) Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization. Cancer 78:2216–2222

    Article  PubMed  CAS  Google Scholar 

  54. Vogt FM, Herborn CU, Hunold P, Lauenstein TC, Schroder T, Debatin JF, Barkhausen J (2004) HASTE MRI versus chest radiography in the detection of pulmonary nodules: comparison with MDCT. AJR Am J Roentgenol 183:71–78

    PubMed  Google Scholar 

  55. Wong CY, Salem R, Raman S, Gates VL, Dworkin HJ (2002) Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. Eur Nucl Med Mol Imaging 29:815–820

    Article  CAS  Google Scholar 

  56. Wong CY, Salem R, Qing F, Wong KT, Barker D, Gates V, Lewandowski R, Hill EA, Dworkin HJ, Nagle C (2004) Metabolic response after intraarterial 90Y-glass micro-sphere treatment for colorectal liver métastases: comparison of quantitative and visual analyses by 18F-FDG PET. J Nucl Med 45:1892–1897

    PubMed  CAS  Google Scholar 

  57. Wong CY, Qing F, Savin M, Campbell J, Gates VL, Sherpa KM, Lewandowski RJ, Nagle C, Salem R (2005) Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging. J Vasc Interv Radiol 16:1101–1106

    PubMed  Google Scholar 

  58. Yang M, Martin DR, Karabulut N, Frick MP (2003) Comparison of MR and PET imaging for the evaluation of liver métastases. J Magn Reson Imaging 17:343–349

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Radiology, University Hospital - Gross-hadern, Ludwig-Maximilians-University of Munich, Mar-chioninistrasse 15, 81377, Munich, Germany

    Tobias F. Jakobs MD

Authors
  1. Tobias F. Jakobs MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology Clínica Universitaria, Universidad de Navarra, Avenida de Pio XII, 36, 31008, Pamplona, Spain

    José I. Bilbao PhD (Professor) (Professor)

  2. Department of Clinical Radiology, University Hospitals - Grosshadern and Innenstadt Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, 81377, Munich, Germany

    Maximilian F. Reiser MD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Jakobs, T.F. (2008). Radiological Detection and Assessment of Tumor Response. In: Bilbao, J.I., Reiser, M.F. (eds) Liver Radioembolization with 90Y Microspheres. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-35423-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-35423-9_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-35421-5

  • Online ISBN: 978-3-540-35423-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation